Toxoplasma gondii F-actin forms an extensive filamentous network required for material exchange and parasite maturation

  1. Javier Periz
  2. Jamie Whitelaw
  3. Clare Harding
  4. Simon Gras
  5. Mario Igor Del Rosario Minina
  6. Fernanda Latorre-Barragan
  7. Leandro Lemgruber
  8. Madita Alice Reimer
  9. Robert Insall
  10. Aoife Heaslip  Is a corresponding author
  11. Markus Meissner  Is a corresponding author
  1. University of Glasgow, United Kingdom
  2. Cancer Research UK Beatson Institute, United Kingdom
  3. University of Vermont, United States

Abstract

Apicomplexan actin is important during the parasite's life cycle. Its polymerization kinetics are unusual, permitting only short, unstable F-actin filaments. It has not been possible to study actin in vivo and so its physiological roles have remained obscure, leading to models distinct from conventional actin behaviour. Here a modified version of the commercially available Actin-Chromobody® was tested as a novel tool for visualising F-actin dynamics in Toxoplasma gondii. Cb labels filamentous actin structures within the parasite cytosol and labels an extensive F-actin network that connects parasites within the parasitophorous vacuole and allows vesicles to be exchanged between parasites. In the absence of actin, parasites lack a residual body and inter-parasite connections and grow in an asynchronous and disorganized manner. Collectively, these data identify new roles for actin in the intracellular phase of the parasites lytic cycle and provide a robust new tool for imaging parasitic F-actin dynamics.

Article and author information

Author details

  1. Javier Periz

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Jamie Whitelaw

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Clare Harding

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Simon Gras

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Mario Igor Del Rosario Minina

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Fernanda Latorre-Barragan

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Leandro Lemgruber

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Madita Alice Reimer

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Robert Insall

    Cancer Research UK Beatson Institute, Bearsden, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Aoife Heaslip

    Department of Molecular Physiology and Biophysics Burlington, University of Vermont, Vermont, United States
    For correspondence
    aoife.heaslip@uconn.edu
    Competing interests
    The authors declare that no competing interests exist.
  11. Markus Meissner

    Division of Infection and Immunity, Institute of Biomedical Life Sciences, University of Glasgow, Glasgow, United Kingdom
    For correspondence
    markus.meissner@glasgow.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4816-5221

Funding

Wellcome (087582/Z/08/Z)

  • Markus Meissner

H2020 European Research Council (ERC-2012-StG 309255-EndoTox)

  • Markus Meissner

Wellcome (WT103972AIA)

  • Clare Harding

National Institute for Health Research (AI121885)

  • Aoife Heaslip

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Anna Akhmanova, Utrecht University, Netherlands

Version history

  1. Received: December 12, 2016
  2. Accepted: March 9, 2017
  3. Accepted Manuscript published: March 21, 2017 (version 1)
  4. Version of Record published: March 31, 2017 (version 2)

Copyright

© 2017, Periz et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,302
    views
  • 738
    downloads
  • 95
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Javier Periz
  2. Jamie Whitelaw
  3. Clare Harding
  4. Simon Gras
  5. Mario Igor Del Rosario Minina
  6. Fernanda Latorre-Barragan
  7. Leandro Lemgruber
  8. Madita Alice Reimer
  9. Robert Insall
  10. Aoife Heaslip
  11. Markus Meissner
(2017)
Toxoplasma gondii F-actin forms an extensive filamentous network required for material exchange and parasite maturation
eLife 6:e24119.
https://doi.org/10.7554/eLife.24119

Share this article

https://doi.org/10.7554/eLife.24119

Further reading

  1. A parasite called Toxoplasma gondii builds a scaffold inside human and other animal cells to help it multiply and cause disease.

    1. Cell Biology
    2. Structural Biology and Molecular Biophysics
    Marcel Proske, Robert Janowski ... Dierk Niessing
    Research Article

    Mutations in the human PURA gene cause the neurodevelopmental PURA syndrome. In contrast to several other monogenetic disorders, almost all reported mutations in this nucleic acid-binding protein result in the full disease penetrance. In this study, we observed that patient mutations across PURA impair its previously reported co-localization with processing bodies. These mutations either destroyed the folding integrity, RNA binding, or dimerization of PURA. We also solved the crystal structures of the N- and C-terminal PUR domains of human PURA and combined them with molecular dynamics simulations and nuclear magnetic resonance measurements. The observed unusually high dynamics and structural promiscuity of PURA indicated that this protein is particularly susceptible to mutations impairing its structural integrity. It offers an explanation why even conservative mutations across PURA result in the full penetrance of symptoms in patients with PURA syndrome.